FDA Approves Elon Musk’s NeuraLink for Human Trials of Brain Implants

Savage Premium Subscription

The FDA has granted approval to Elon Musk’s brain implant company, NeuraLink, to carry out clinical studies on humans.

“This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people,” tweeted the official account of NeuraLink on Thursday afternoon.

Musk has long been predicting that the FDA would eventually allow the brain implant company to carry out studies involving humans.

However, the FDA rejected the company’s initial application in 2022, citing safety concerns with the product. The company now appears to have overcome those concerns.

The goal of NeuraLink is to develop brain-computer interfaces with the goal of human enhancement in a wide variety of areas — a goal sometimes described as transhumanism.

In previous interviews, Elon Musk has said he hopes NeuraLink can “address brain injuries or spinal injuries and make up for whatever lost capacity somebody has with a chip.”

In 2021, NeuraLink released video showing monkeys using neural signals to play the video game Pong. This milestone had previously been achieved by scientists in lab settings, but not by a commercial company developing a product aimed at everyday consumers.